107 results
Page 3 of 6
8-K
EX-99.1
kxxdw5g sn
25 Feb 22
Akero Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
7:15am
8-K
EX-99.1
th7z86 sw0bku
9 Sep 21
A Global Disease, A Pioneering Treatment Corporate Presentation September 2021
4:46pm
8-K
x3uu57p lc3516x
2 Jun 21
Submission of Matters to a Vote of Security Holders
4:13pm
S-3ASR
mf480j7l qb0i9i1gwm5
18 May 21
Automatic shelf registration
6:01am
8-K
EX-99.2
j0j z76voaou
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
jkpvld1nh8kp0nbp
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
1a5se1wsq 8oiial
13 Apr 21
A Global Disease, A Pioneering Treatment Corporate Presentation April 2021
8:30am
8-K
EX-99.1
pfg8ad zsh6tfi6uyzq
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
2usyxe nk6j
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
EX-3.1
rbrc7uule83g jb2
12 Mar 21
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
EX-99.1
a5onj1gw876rn6
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
jef5az 3lhr
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am